Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2008
10/15/2008CN101284835A Dimeric sesquiterpene lactone compounds, preparation method and applications thereof
10/15/2008CN101284834A Bi-inulicin 1, preparation method and applications thereof
10/15/2008CN101284833A Bi-inulicin 4, preparation method and applications thereof
10/15/2008CN101284823A Arctigenin pro-drug, preparation method and use thereof
10/15/2008CN101284818A Solid forms of (E) -1- (4- ( (1R, 2S, 3R) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/15/2008CN101284151A Production method of modified surgical catgut of point heeling-in therapy
10/15/2008CN101284114A Medicine for treating rheumatism and rheumatoid disease
10/15/2008CN101284097A Plaster for curing the protrusion of lumbar intervertebral discs, hyperosteogeny and rheumatoid and preparation method thereof
10/15/2008CN101284089A Chinese medicine preparation for curing neck, shoulder, waist and leg pain
10/15/2008CN101284088A Chinese medicine preparation for effectively relieving pain caused by acute and chronic soft tissue injury
10/15/2008CN101284076A New process of Shujinhuoxue pill and quality control method
10/15/2008CN101284057A Yaotongning medicine and preparation method thereof
10/15/2008CN101284049A Quality control process of double coptis effervescent tablets
10/15/2008CN101284029A Pain relieving, hemostasia and antipruritic drug powder
10/15/2008CN101284016A Bezoar vitro bred and solid oral preparation containing the bezoar
10/15/2008CN101284005A Application of indirubin for preparing medicine for preventing blood vessel from regenerating
10/15/2008CN101284004A Application of two bi-sesquiterpenes compound for preparing antineoplastic and antiinflammatory medicine
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283987A Chloroquine liposomes freeze-dried powder injection and preparation method thereof
10/15/2008CN101283828A Beverage for sobering up, reducing fever and protecting liver
10/15/2008CN101283794A Radix Aconitum kusnezoffii medicated diet powder and its preparation method
10/15/2008CN101283715A Health-care beverage health preservation tea
10/15/2008CN100425621C Steroid imidazole salt compound and its preparing process
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425591C Sulfonyl diphenylethyllene endocompound and its preparation method and pharmaceutical uses
10/15/2008CN100425286C Purified ustading and its preparation method and medicinal composition containing said ustading
10/15/2008CN100425280C Chinese medicinal composition for treating rheumatoid arthritis
10/15/2008CN100425264C Granule medicine contg. high oxygen with function for improving activity fo muscles and bones, and its supplementary skill exercise
10/15/2008CN100425253C Process for preparing total saponin of anemone rhizome
10/15/2008CN100425251C Pharmaceutical composition for treating bone diseases and method for preparing the same
10/15/2008CN100425250C Isatis root extract and its preparation method
10/15/2008CN100425243C Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis
10/15/2008CN100425227C Chinese medicine for relieving exterior syndrome, regulating stomach and eliminatnig dampness and its production
10/14/2008US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008CA2436925C Crystalline glucosamine sulphate metal salts
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2354576C Pharmaceutical preparation for inhalation of an opioid
10/14/2008CA2338680C Medicinal aerosol formulations
10/14/2008CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2318128C Oral liquid compositions
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008121742A2 Inhibitors of bruton's tyrosine kinase
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008121066A1 Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors
10/09/2008WO2008121065A1 Novel pyrrolidine derivatives as antagonists of the chemokine receptor
10/09/2008WO2008120966A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management
10/09/2008WO2008120965A1 Pharmaceutical composition comprising a combination of an anti-arthritic agent, a chondroprotective agent, and an anti-inflammatory agent
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120766A1 Analgesic composition
10/09/2008WO2008120765A1 Analgesic composition
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008119917A1 Quinoline derivatives as crth2 receptor ligands
10/09/2008WO2008119825A2 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119790A2 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes
10/09/2008WO2008119771A2 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119685A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119185A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008WO2008100622A3 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/09/2008WO2008098871A3 Use of chitosans for the treatment of nail inflammatory diseases
10/09/2008WO2008058210A3 Local administration of gallium compositions to treat pain
10/09/2008WO2008055146A3 Formulations of phospholipase enzyme inhibitors
10/09/2008WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249164 Antimicrobial and Antinflammatory Composition
10/09/2008US20080249157 Novel Inhibitors of the Lfa-1/Icam-1 Interaction and Uses Thereof
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249140 Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents
10/09/2008US20080249132 Piperidine Carboxyamide Derivate Suitable as Tachykinin Receptor Antagonist
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249091 Indoles Useful in the Treatment of Inflammation
10/09/2008US20080249087 Heterocylic antiviral compounds
10/09/2008US20080249077 glucocorticoid receptor agonists; to treat inflammatory and allergic conditions; Fluoromethyl(6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
10/09/2008US20080249072 Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators
10/09/2008US20080249047 Modulation of Inflammation Through Modulation of Elavl1/HuR Expression
10/09/2008US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
10/09/2008US20080249037 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus
10/09/2008US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter
10/09/2008US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity
10/09/2008US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 1272